FundingHealthcare & Life Sciences
Redcliffe Lifetech raises $61 million Series B
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
Series B
- Redcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic tests
- It raised $61 million in Series B funding led by LeapFrog Investments, with participation from Healthquad, Schroders, and others
- The company plans to expand into tier 2, 3 and 4 cities and scale its platform to reach 500 million Indians in five years
What happened
- Redcliffe Lifetech raised $61 million in a Series B funding round.
- The round was led by LeapFrog Investments, a global impact investor.
- Participating investors included Healthquad, Schroders, LC Nueva, and Growth Spark Ventures.
- Existing investors Chiratae Ventures and Alkemi Venture Partners also participated.
- The company will use the funds to expand into tier 2, 3 and 4 cities and scale its platform.
- It also plans to increase product offerings in radiology, disease data profiling, and lifestyle management.
- Redcliffe Lifetech aims to reach 500 million Indians within five years.
Why it matters
- The diagnostics market in India is growing rapidly, especially in smaller cities.
- Redcliffe offers tests at 25% to 60% lower prices than traditional competitors.
- The company has already built a network of 22 labs across 14 cities and 500 offline collection centres.
- It previously raised a $10 million Series A in 2021.
The business
- Redcliffe Lifetech is an omnichannel diagnostics platform offering over 3,500 pathology and specialised tests, including genetics.
- It operates 22 labs across 14 cities, several NABL accredited, and has 500 offline collection centres.
- The company has 400 phlebotomists operating in over 100 cities with home sample collection.
- Its proprietary technology platform covers consumer experience, lab operations, fulfillment, and CRM.
- Redcliffe has piloted drone technology for supply chain to reach smaller cities and remote areas.
- It co-developed live remote temperature tracking for sample integrity during collection.
- The website reports 1 crore+ lives touched, 80+ self-owned certified labs, 2,000+ collection centres, and 1,500+ trained phlebotomists.
- It offers health checkup packages, smart reports with colour-coded insights, expert consultation, AI assistance, and diet plans.
- Redcliffe also has Femcliffe Health Packages (India’s first she-centric diagnostic platform) and GeneCliffe for DNA, chromosome and protein insights.
The founders
DJ
Dheeraj Jain
FounderWho put in money
- LeapFrog Investments lead — Global impact investor focused on healthcare and financial services in emerging markets.
- Healthquad participated — Healthcare-focused investment firm.
- Schroders participated — Global asset management company.
- LC Nueva participated — Investment firm.
- Growth Spark Ventures participated — Venture capital firm.
- Chiratae Ventures existing — Indian venture capital firm investing in technology startups.
- Alkemi Venture Partners existing — Venture capital firm.
In numbers
$61 millionSeries B amount · 2022
$10 millionPrevious Series A amount · 2021
22Labs · 2022
14Cities with labs · 2022
500Offline collection centres · 2022
400Phlebotomists · 2022
100+Cities with home collection · 2022
1 crore+Lives touched (website) · 2022
80+Self-owned certified labs (website) · 2022
2,000+Collection centres (website) · 2022
1,500+Trained phlebotomists (website) · 2022
25% to 60%Price reduction vs competitors · 2022
What happens next
- Expand reach into tier 2, 3 and 4 cities.
- Scale the platform and increase product offerings in radiology, disease data profiling, and lifestyle management.
- Reach 500 million Indians within five years.
Earlier rounds
- 2021 · Series A · $10 million
Words to know
- Series B
- A later-stage funding round for companies that have already proven their business model and need capital to scale.
- Omnichannel
- A business approach that provides a seamless customer experience across multiple channels, such as online, mobile, and physical stores.
- NABL
- National Accreditation Board for Testing and Calibration Laboratories, an Indian accreditation body for testing and calibration labs.
- Phlebotomist
- A trained professional who draws blood from patients for medical testing.
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 13 August 2023 | growth | $80 million | |
| 29 September 2022 | Series B | $100-125 million |
Other articles talking about it
Terms in this story
- Tier-2 startups: A growing share of Indian startups now come from tier-2 and tier-3 cities and towns, helped by cheap data, lower costs and local problems that big-city founders do not see. Raising money and hiring senior talent remain the main hurdles.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Redcliffe Labs → · All startup news on 6 May 2022 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →